Google launches new program to serve Houston's minority small business owners

new to hou

The Grow with Google Digital Coaches program has expanded to Houston. Photo via Unsplash

A new Google initiative is expanding its Texas presence this month. The Grow with Google's Digital Coaches program, which has already launched in Austin, has expanded to the Bayou City — making the Lone Star State the only state to have two locations of this entrepreneur-centric tool.

The program aims to provide digital skills training and coaching to Black and LatinX small business owners and create economic opportunity. Houston is one of eight new cities the program has recently expanded into.

"Houston has a vibrant and growing Black and LatinX small business community," says Lucy Pinto, Google's Digital Coach program manager, in a news release. "The Digital Coaches program will provide business owners in these communities with ongoing workshops and hands-on coaching sessions focused on techniques and digital tools to reach new customers, thrive online and grow."

Houston entrepreneur Joy M. Hutton, founder of Joy of Consulting, will serve as the Grow with Google Digital Coach for Houston. Hutton also runs a restaurant-focused consulting business called The Restaurant Girl and founded go GLAM, a beauty on demand platform.

"The Grow with Google team is making an effort to close the gap in resources that Black and LatinX small business owners have not generally had access to — in Houston and beyond," Hutton says in the release. "I live and breathe entrepreneurship, so I'm honored to participate in the Google Digital Coaches program and excited to work with Houston entrepreneurs who are traditionally underrepresented."

Joy M. Hutton will lead Grow with Google in Houston. Photo courtesy

According to the release, the program is expanding with inclusion in mind. This year, the program will grow to 20 mentors.

"As the representative of Houston's 18th District, a diverse and historic district, I know firsthand the importance and positive impact that investing in diverse communities and their residents can have on the entire population," says Rep. Sheila Jackson Lee in the release. "As Houston continues to prosper and grow, it is critical that we continue to invest in our minority-owned and small businesses to ensure an even brighter economic future for our city."

The program's first free workshop is called Connect with Customers and Manage Your Business Remotely and will be held virtually tomorrow, Friday, November 20, at 5:30 p.m. Moving forward, Grow with Google workshops will be hosted by Hutton on a regular basis, including the following sessions:

    • Dec. 3 at 5 p.m. CDT - Get Your Local Business on Google Search and Maps
    • Dec. 10 at 5 p.m. CDT - Reach Customers Online with Google
    • Dec. 17 at 5 p.m. CDT - Digital Skills for Everyday Tasks

    Both Google as well as local leadership are excited for the opportunities this program will provide Houstonians.

    "As a 'majority-minority' city that is the fourth-largest in the U.S., it is critical that our Black and LatinX business owners have the tools and knowledge to reach new customers, grow their businesses and help continue to make Houston a prosperous, skilled and inclusive city," Mayor Sylvester Turner says in the release. "The city of Houston is appreciative for the opportunity to provide invaluable resources and opportunities to our city's Black and LatinX small business owners."

    Ad Placement 300x100
    Ad Placement 300x600

    CultureMap Emails are Awesome

    Property Showcase

    Greentown Labs names Lawson Gow as its new Houston leader

    head of hou

    Greentown Labs has named Lawson Gow as its Head of Houston.

    Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

    According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

    “I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

    Gow has also held analyst, strategy and advising roles since graduating from Rice University.

    “We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

    Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

    Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

    Greentown also named Naheed Malik its new CFO in January.

    Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

    ---

    This article originally appeared on our sister site, EnergyCapitalHTX.com.

    Houston foundation grants $27M to support Texas chemistry research

    fresh funding

    Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

    According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

    • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
    • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
    • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

    Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

    The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

    Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

    “Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

    New Houston biotech co. developing capsules for hard-to-treat tumors

    biotech breakthroughs

    Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

    Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

    The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

    This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

    From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

    “They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

    Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

    “We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

    When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

    “This isn’t just another cell therapy,” Chakrabarti says.

    "Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.

    View All Listings